Control of Ca2+ influx by manipulation of Ca2+ and/or Ca2+ antagonist in cardioplegic arrest.

Maximum deactivation of the contractile elements using Ca2+ minimizes oxygen requirements during global ischemia, Ca2+ antagonists and Ca(2+)-free cardioplegia solutions are methods by which the Ca2+ flux can be manipulated. This study was performed with 5 experimental groups: 1) Standard cardioplegia (with Ca2+), 2) Ca(2+)-free cardioplegia, 3) Ca(2+)-free cardioplegia plus verapamil (0.5 mg/L), 4) Verapamil cardioplegia (with Ca2+), and 5) Ca(2+)-free cardioplegia, in which verapamil was administered at the onset of reperfusion (0.5 mg/L). Cardiac functions, heart rate, edema formation, and creatine kinase concentration were measured before and after 70 min of ischemia at a myocardial temperature of 20 degrees C. Ca(2+)-free cardioplegia may be beneficial under hypothermic conditions, but the "Ca2+ paradox" was still a matter of concern. Reperfusion with verapamil did not protect from reperfusion-related injuries. However, the use of verapamil provided more protection than did standard or Ca(2+)-free cardioplegic solutions. Since verapamil did not maintain membrane integrity during ischemia when combined with Ca(2+)-free cardioplegic solutions (prominent edema formation was observed), its combination with Ca(2+)-containing cardioplegic solutions is recommended.

[1]  G. Hicks,et al.  Verapamil crystalloid cardioplegia: an experimental evaluation of dose-response relationships. , 1987, The Journal of surgical research.

[2]  W. Daggett,et al.  Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution. , 1987, The Journal of thoracic and cardiovascular surgery.

[3]  J. Jong Cardioplegia and calcium antagonists: a review. , 1986 .

[4]  G. Buckberg,et al.  Reperfusate composition: benefits of marked hypocalcemia and diltiazem on regional recovery. , 1986, The Journal of thoracic and cardiovascular surgery.

[5]  A. Van der Laarse,et al.  Cold ischemic arrest: comparison of calcium-free and calcium-containing solutions. , 1985, The Annals of thoracic surgery.

[6]  G. Hicks,et al.  Verapamil potassium cardioplegia and cardiac conduction. , 1985, The Annals of thoracic surgery.

[7]  M. Shattock,et al.  Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart. , 1984, Circulation.

[8]  D. Hearse,et al.  Calcium and cardioplegia. The optimal calcium content for the St. Thomas' Hospital cardioplegic solution. , 1984, The Journal of thoracic and cardiovascular surgery.

[9]  J. Standeven,et al.  Cold blood potassium diltiazem cardioplegia. , 1984, The Journal of thoracic and cardiovascular surgery.

[10]  E. Gersing,et al.  Calcium-free cardioplegia--pro. , 1983, European heart journal.

[11]  P. Jynge Calcium-free cardioplegia--contra. , 1983, European heart journal.

[12]  R. Guyton,et al.  Calcium-channel blockade as an adjunct to heterogeneous delivery of cardioplegia. , 1983, The Annals of thoracic surgery.

[13]  W. Nayler Calcium and cell death. , 1983, European heart journal.

[14]  D. Hearse,et al.  Cardioplegia and slow calcium-channel blockers. Studies with verapamil. , 1983, The Journal of thoracic and cardiovascular surgery.

[15]  M. A. Chiong Metabolism of the perfused rabbit heart. V. Verapamil-induced release of creatine kinase. , 1982, Canadian journal of physiology and pharmacology.

[16]  P. Poole‐Wilson,et al.  The Effects of Verapamil, Quiescence, and Cardioplegia on Calcium Exchange and Mechanical Function in Ischemic Rabbit Myocardium , 1982, Circulation research.

[17]  P. Ludbrook,et al.  The first American clinical trial of nifedipine in cardioplegia. A report of the first 12 month experience. , 1981, The Journal of thoracic and cardiovascular surgery.

[18]  G. Magovern,et al.  Improved myocardial protection with nifedipine and potassium-based cardioplegia. , 1981, The Journal of thoracic and cardiovascular surgery.

[19]  T. Gardner,et al.  Mechanism of defective oxygen extraction following global ischemia. , 1981, The Journal of surgical research.

[20]  V. Gott,et al.  Mechanism of elevated left ventricular end-diastolic pressure after ischemic arrest and reperfusion. , 1981, The American journal of physiology.

[21]  K. Lanoue,et al.  Effects of Ca2+ antagonism on energy metabolism: Ca2+ and heart function after ischemia. , 1980, The American journal of physiology.

[22]  R. E. Clark,et al.  Nifedipine: a myocardial protective agent. , 1979, The American journal of cardiology.

[23]  V. Gott,et al.  Comparison of Myocardial Protection with Nifedipine and Potassium , 1979, Circulation.

[24]  P. Jynge,et al.  Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. , 1977, The Journal of thoracic and cardiovascular surgery.

[25]  G. Tyers,et al.  Isolated heart perfusion techniques for rapid screening of myocardial preservation methods. Anoxia versus ischemia. , 1975, The Annals of thoracic surgery.

[26]  W. C. Hülsmann,et al.  Paradoxical Influence of Calcium Ions on the Permeability of the Cell Membranes of the Isolated Rat Heart , 1966, Nature.

[27]  G. Buckberg Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. , 1987, The Journal of thoracic and cardiovascular surgery.